Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Cidofovir in Recurrent Respiratory Papillomatosis
NCT02555800Phase 2Unknown
- Sponsor
- Centro de Investigación en Enfermedades Infecciosas
- Start
- Dec 2014
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in recurrent respiratory papillomatosis (RRP), sponsored by Centro de Investigación en Enfermedades Infecciosas. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
recurrent respiratory papillomatosis (RRP)
Beyond the preview
Go deeper on NCT02555800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555800.